gMendel® announces CE marking for its Phivea® v1.0.0 platform - #BHHMembersInitiatives
Become a member
About us
Overview The Team Ambassadors Location & Contact Get your office at the Hub
Members
Members Become a member
Events
Next events Past events ISE 2026 4YFN 2026 Health Revolution Congress Organize your event at BHH
Reports
Digital Health Reports
e-health validations
News
Recinte Modernista de Sant Pau
Carrer de Sant Antoni Maria Claret 167
08025 Barcelona, Spain
Home News gMendel® announces CE marking for its Phivea® v1.0.0 platform - #BHHMembersInitiatives
Back

gMendel® announces CE marking for its Phivea® v1.0.0 platform - #BHHMembersInitiatives

MAY 6, 2022 Members' News
BHH member gMendel®, a Danish medical technology startup aiming to transform the diagnosis of genetic disorders for better disease management, announced today it has achieved CE marking for its Phivea® v1.0.0 platform, a novel screening technology for the detection of Klinefelter Syndrome. Following the successful validation and a comprehensive performance evaluation, documenting the clinical applicability of its technology, gMendel® is now entitled to sell the Phivea® v1.0.0 platform in the EU, starting with a registration in Denmark. The Phivea® v1.0.0 platform will be marketed as an In Vitro Diagnostic (IVD) medical device product under the Directive 98/79/EC for In Vitro Diagnostic medical devices. “The CE marking of the Phivea® v1.0.0 platform is a major milestone for gMendel®”, said Zoran Velkoski, co-founder of gMendel®. “In parallel with our strong patent portfolio strategy, our recently-obtained ISO 13485 certification and the CE marking pave the way for the commercial launch of more advanced products in the highly competitive IVD market, as defined in our product roadmap”, explained Zoran Velkoski.  About the Phivea® v1.0.0 platform Phivea® v1.0.0 is an in vitro screening software tool for the diagnosis of Klinefelter syndrome based on DNA sequencing process. It offers screening tests capabilities, based on the data coming from third-party genome sequencers. Phivea® employs advanced Artificial Intelligence and customized Deep Learning architectures at all levels of the learning process, from feature extraction to assessment and follow-up care. Following a multi model fusion strategy, the Platform combines outcomes of individual models into a single, accurate medical interpretation. More about Phivea® v1.0.0 here. About CE marking for medical devices Many products require CE marking before they can be sold in the EU. CE marking indicates that a product has been assessed by the manufacturer and deemed to meet EU safety, health and environmental protection requirements. The CE marking affixed to a medical device demonstrates compliance with the EU legislation in force and therefore can be made available for distribution or use, e.g. to a distributor, healthcare professional or patient. More about CE marking in medical devices here.  
You may also like
 See all
June 05, 2026 Members' News
Scilife Training | The CSV-to-CSA roadmap: modernizing GxP validation
Does validation feel heavier every year?   If growing documentation, audit pressure, and complex validation processes sound familiar, this webinar is for you. Join Sachin Bhandari, Quality IT and Digitalization Leader, and owner at Trustbridge Compliance, and Àngel Buendía, Scilife's Knowledge Manager, to learn how a modern CSA-based approach can simplify validation while keeping you compliant.
Read more
June 05, 2026 Members' News
Digital health Innovation in behavioral health x Neamah Health Consulting
Digital mental and behavioral health is one of the fastest-evolving areas in healthtech—but also one of the most complex, misunderstood, and full of hidden challenges. In this session, we’ll explore behavioral health innovation from a product perspective, unpacking what makes this sector fundamentally different, the most common myths and mistakes teams fall into, the key lessons learned from building in this space, and where the real opportunities for innovation are today.
Read more
June 05, 2026 Members' News
Dycem Joins Barcelona Health Hub!
Joining Barcelona Health Hub marks an important step for Dycem as the company continues to strengthen its presence within the healthcare sector. It creates new opportunities to stay close to innovation, collaborate with leading organisations, and better understand the evolving needs of healthcare environments.
Read more
June 05, 2026 Members' News
Regulatory Labs AI Platform is redefining regulatory compliance in Pharma and Cosmetics with AI
The Pharma and Cosmetics industries are facing increasing regulatory complexity, shorter innovation cycles and growing pressure to launch products faster without compromising compliance or safety. In this context, Xtremis has developed Regulatory Labs AI Platform, an AI-powered solution designed to transform the way laboratories, R&D teams and regulatory departments analyze and validate formulations.
Read more
June 05, 2026 Members' News
Scilife CaseLab | Inspection-ready by design: scaling GxP quality systems for DACH life sciences
Many DACH biotech and life sciences companies focus heavily on clinical development early on, only to face operational and compliance challenges as they scale across GCP, GMP, and QA activities. Disconnected systems, fragmented documentation, and manual processes can quickly create complexity.  In this session, Anke Ackermann (neé Zampich), GxP Strategy Advisor, Owner of QA-System, Daniel Vivas, Account Executive, and Angel Buendía, Knowledge Manager, will discuss how growing companies can build a connected, inspection-ready quality ecosystem from the start.
Read more
June 05, 2026 Members' News
WHEN INNOVATION MEETS HEALTH
AI, opportunities, challenges and support for R&D&I projectsIn-person event | Limited capacityJune 11th, 10:00 a.m. | Valencia
Read more
June 01, 2026 Members' News
Scilife CaseLab | From local to global: scaling your QMS for UK–EU operations
Expanding from the UK into the EU brings new opportunities, but it also adds complexity to your quality system. That’s why Scilife and Rephine are joining forces to show you how to scale without losing control. In this practical CaseLab, we’ll walk you through what it really takes to build a connected, inspection-ready quality system for international growth, combining expert insights with a real-life use case.
Read more
May 13, 2026 Members' News
ECIJA Barcelona joins Barcelona Health Hub to drive legal innovation in digital health
A strategic collaboration at the intersection of legal expertise, regulatory frameworks, and digital health innovation, aimed at supporting startups, scaleups, and corporates in navigating complex legal challenges and accelerating sustainable growth in the healthtech ecosystem.
Read more
April 29, 2026 Members' News Events of the ecosystem
TuoTempo Webinar | The power of healthcare marketplaces: turning your CRM into a 24/7 patient acquisition and growth channel
TuoTempo, a provider of digital patient journey and access management solutions for healthcare organizations, will host an upcoming live webinar exploring how healthcare providers can strengthen their digital visibility and turn their existing technology stack into a sustainable patient acquisition channel.
Read more
April 24, 2026 Events of the ecosystem Members' News
How to manage the arrival of AI in companies
GironaHub will host an exclusive session with Genís Roca, exploring how artificial intelligence is reshaping organisations and redefining business strategy for senior executives.
Read more